Overview
- Police arrested Sresan Pharmaceuticals owner G. Ranganathan in Chennai on charges including culpable homicide and drug adulteration, and he is being brought to Madhya Pradesh on transit remand.
- Tamil Nadu has suspended Sresan’s operations and sealed the Kancheepuram unit, with state officials saying permanent licence cancellation will follow after a brief inquiry; two senior state drug inspectors were suspended for oversight failures.
- The confirmed death toll rose to 22 children, mostly from Chhindwara in Madhya Pradesh, with several others still hospitalised in Nagpur after consuming Coldrif linked to acute kidney injury.
- Regulators banned and recalled Coldrif, Respifresh TR and ReLife, halted production at implicated facilities, and multiple states conducted seizures and inspections to remove stocks and test samples.
- India’s drug regulator told the WHO the syrups were not exported, while the WHO sought details and highlighted gaps in domestic DEG/EG screening for syrup medicines.